SEC Form 4 · accession 0001209191-18-014705
PURE BIOSCIENCE, INC. · PURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David J Pfanzelter
Officer — Chairman of the Board · Director
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 7:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006028
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $0.78 | Feb 26, 2018 | A | 200,000 | A | — | Feb 26, 2023 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F125% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018.